What’s the deal with Azopharma?

- Last updated on GMT

Related tags: English-language films

US contract pharmaceutical developer Azopharma has not yet confirmed or denied industry rumours that it has gone bankrupt.

According to numerous posts on the Topix​ message board, the Florida-headquartered company closed its doors for the last time last Friday, sending home its workforce of more than 100 employees.

Outsourcing-pharma, which also received a reader question about Azopharma’s current status, has yet to hear back from the firm despite several telephone calls and emails.

No information is provided on Azopharma’s website, although the landing page still lists the firm as an attendee at next week’s Interphex conference in New York.

Related news

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars